Is Buspar (buspirone) safe in bipolar disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Buspar (buspirone) is generally not recommended as a first-line treatment for bipolar disorder, as it may exacerbate manic symptoms or induce mood swings 1. However, in some cases, it may be used off-label to treat anxiety symptoms in patients with bipolar disorder, but only under close supervision and at low doses (5-10 mg twice daily) 1.

Key Considerations

  • Close supervision: Patients with bipolar disorder who are taking buspirone should be closely monitored for signs of manic episodes or worsening bipolar symptoms 1.
  • Low doses: Buspirone should be started at a low dose and gradually increased as needed, while also considering the use of a mood stabilizer to mitigate potential risks 1.
  • Mood stabilizer: The use of a mood stabilizer may be necessary to mitigate the potential risks of buspirone in patients with bipolar disorder 1.

Potential Risks

  • Manic episodes: Buspirone may trigger manic episodes or worsen bipolar symptoms in some patients 1.
  • Anxiety symptoms: Buspirone may be effective in treating anxiety symptoms in patients with bipolar disorder, but it should be used with caution and under close supervision 1.
  • Discontinuation due to adverse events: Discontinuation due to adverse events was lower with bupropion than with buspirone in some studies 1.

From the Research

Safety of Buspar in Bipolar Disorder

  • There is limited direct evidence on the safety of Buspar (buspirone) in bipolar disorder 2, 3, 4, 5, 6.
  • Buspirone is primarily used to treat generalized anxiety disorder and has been shown to be effective in reducing anxiety symptoms in patients with depressive disorders 3, 5, 6.
  • However, its use in bipolar disorder is not well-studied, and most guidelines recommend the use of mood stabilizers, atypical antipsychotics, and antidepressants as first-line treatments for bipolar depression 2, 4.
  • Some studies suggest that buspirone may be useful in treating anxiety symptoms in patients with depressive disorders, including those with bipolar disorder, but more research is needed to fully understand its safety and efficacy in this population 5, 6.
  • A recent study found that adjunctive buspirone therapy effectively improved anxiety symptoms in depressed patients taking antidepressants, regardless of baseline symptom severity or buspirone dosage, with few adverse events reported 6.

Potential Risks and Benefits

  • The use of buspirone in bipolar disorder may be associated with a risk of precipitating a switch into mania, although this risk may be minimized when used in combination with a mood stabilizer 4.
  • Buspirone may also have benefits in terms of reducing anxiety symptoms and improving depressive symptoms in patients with bipolar disorder, although more research is needed to fully understand its effects in this population 5, 6.
  • The safety and efficacy of buspirone in bipolar disorder may depend on various factors, including the patient's specific diagnosis, symptom severity, and concomitant medications 2, 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Buspirone in clinical practice.

The Journal of clinical psychiatry, 1990

Research

A review of acute treatments for bipolar depression.

International clinical psychopharmacology, 2004

Research

Buspirone: Back to the Future.

Journal of psychosocial nursing and mental health services, 2015

Research

Effectiveness of Buspirone in Alleviating Anxiety Symptoms in Patients with Depressive Disorder: A Multicenter Prospective Observational Study in Korea.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.